Evidence map›Paper›PMID 41219638›Full record

SynthesisJournal of epidemiology and global health2025

The Impact of Diagnostic Delays and Timeliness of Response on Ebola Disease outbreak-level case-fatality Ratios in Uganda (2000-2023): a Rapid Systematic Review and meta-analysis.

George Paasi, Sam Okware, Peter Olupot-Olupot

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Journal of epidemiology and global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

George PaasiClinical trials department, Mbale Clinical Research Institute, Mbale, Uganda. georgepaasi8@gmail.com.ORCID http://orcid.org/0000-0001-6360-0589
Sam OkwareUganda national Health Research Organisation (UNHRO), Entebbe, Uganda.ORCID http://orcid.org/0000-0001-8448-0301
Peter Olupot-OlupotClinical trials department, Mbale Clinical Research Institute, Mbale, Uganda.ORCID http://orcid.org/0000-0002-5757-609X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUganda has experienced seven laboratory-confirmed Ebola virus disease (EBOD) outbreaks from 2000 to 2022, with reported case-fatality ratios (CFRs) varying widely. The influence of diagnostic and response delays on outbreak-level mortality has not been systematically assessed. We conducted a rapid systematic review and meta-analysis to quantify the effect of diagnostic and response delays on outbreak-level mortality.

methodsWe registered the review on OSF and adhered to PRISMA-2020 guidelines. We searched PubMed, Embase, Scopus, Web of Science, WHO Global Index Medicus, and grey literature through 30 April 2025. Eligible reports described laboratory-confirmed human EBOD in Uganda (2000-2022) and reported case counts, deaths, or quantitative timeliness metrics. Outbreak-level CFRs were meta-analyzed using random-effects models with Freeman-Tukey transformation (metafor package in R). Mixed-effects meta-regression assessed the association between continuous delay metrics and transformed CFR.

resultsFifteen reports met inclusion criteria, spanning 741 confirmed cases and 358 deaths. The pooled CFR was 45.4% (95% CI: 26.2%-65.2%; I² = 87.8%) across seven outbreaks. By species, Sudan ebolavirus outbreaks (n = 5) had a CFR of 44.6% (95% CI: 33.7%-55.6%), Bundibugyo ebolavirus (n = 1) 24.8% (95% CI: 18.2%-32.1%), and Zaire ebolavirus (n = 1) 100% (95% CI: 61.2%-100.0%). In meta-regression, each additional day from first case report to specimen collection was associated with a significant increase in CFR (β = 0.142 on the transformed scale; p = 0.025; R² = 62%), translating to an approximate absolute increase of 3.8% points in CFR per day at a baseline risk of 45%. Conversely, longer delays from symptom onset in the index case to national outbreak declaration were linked to a slight decrease in CFR (β = - 0.00765; p = 0.047).

conclusionsUganda's EBOD outbreaks exhibit high and variable mortality, with diagnostic delays substantially amplifying case-fatality. Rapid specimen collection and prompt public health responses are critical to reducing EBOD mortality. Strengthening laboratory networks and accelerating declaration protocols should be central to future outbreak preparedness in Uganda and similar contexts.

Indexed as

Delayed DiagnosisDisease OutbreaksHemorrhagic Fever, EbolaHumansTime FactorsUgandaBundibugyo ebolavirus (BDBV)Case-fatality ratioDiagnostic timelinessEbola virus diseaseOutbreak responseSudan ebolavirus (SUDV)Systematic review and meta‐analysisUgandaZaire ebolavirus (EBOV)

Identifiers

PMID41219638
PMCPMC12605935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.